ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
A Study of AK112 as Consolidation Treatment for Patients With Limited Stage Small-cell Lung Cancer Who Have Not Progressed Following Concurrent Chemoradiation Therapy
- Status
- RECRUITING
- Phase
- PHASE3
Efficacy and Biomarkers of the Second-line Treatment of Adebelizumab Combined With Irinotecan Liposome in Advanced Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Limertinib Plus Carboplatin and Etoposide for EGFR-mutant NSCLC With SCLC Transformation After EGFR-TKI Progression
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of SYS6040 for Injection in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Prospective, Single-arm, Phase II Clinical Study of Irinotecan Hydrochloride Liposome Injection Combined With Platinum and Immune Checkpoint Inhibitors Combined With Anlotinib for the Maintenance of Extensive Small Cell Lung Cancer After First-line Induction
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Study of NMS-03305293 in Adult Patient With Relapsed Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Immunonutrition Reduces Acute Esophagitis After Thoracic Radiotherapy in Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Association of Thoraco-mediastinal Radiotherapy With Maintenance Immunotherapy Treatment With Atezolizumab
- Status
- RECRUITING
- Phase
- PHASE2
Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC
- Status
- RECRUITING
- Phase
- PHASE2
INK Cells As Maintenance Therapy After Chemoradiotherapy for Small Cell Lung Cancer
- Status
- ENROLLING_BY_INVITATION
- Phase
- EARLY_PHASE1
A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)
- Status
- RECRUITING
- Phase
- N/A
Study of IBI3009 in Participants with Unresectable, Metastatic or Extensive-Stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Phase III Study of YL201 in Relapsed Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3